{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T22:40:09Z","timestamp":1715985609183},"reference-count":21,"publisher":"Informa UK Limited","issue":"7","funder":[{"name":"Independent Regulators Group","award":["95-125-07"],"award-info":[{"award-number":["95-125-07"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Immunotherapy"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.2217\/imt.12.61","type":"journal-article","created":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T14:35:17Z","timestamp":1343831717000},"page":"671-674","source":"Crossref","is-referenced-by-count":3,"title":["Concurrent HER2 Vaccination and Inhibition of Kinase Activity: Safety and Immunogenicity"],"prefix":"10.1080","volume":"4","author":[{"given":"Huguette","family":"Albrecht","sequence":"first","affiliation":[{"name":"University of California at Davis, School of Medicine, Department of Public Health Sciences, Sacramento, CA, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2012,8]]},"reference":[{"key":"e_1_3_2_3_1_1","doi-asserted-by":"publisher","DOI":"10.4161\/cbt.11.9.15045"},{"key":"e_1_3_2_3_2_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djs033"},{"key":"e_1_3_2_3_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/35052073"},{"key":"e_1_3_2_3_4_1","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djk134"},{"key":"e_1_3_2_3_5_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.3798106"},{"key":"e_1_3_2_3_6_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra043186"},{"key":"e_1_3_2_3_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.clinthera.2009.11.029"},{"key":"e_1_3_2_3_8_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00262-010-0869-2"},{"key":"e_1_3_2_3_9_1","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-10-28"},{"key":"e_1_3_2_3_10_1","doi-asserted-by":"crossref","unstructured":"Limentani SA CuriglianoG CamponeM et al. dHER2 cancer immunotherapeutic: clinical response in breast cancer patients is associated with an induction of functional antibodies and the generation of specific T cells. Presented at: 30th Annual San Antonio Breast Cancer Symposium. San Antonio TX USA 13\u201316 December 2007 (Abstract 106 S7).","DOI":"10.1007\/s10549-007-9793-3"},{"key":"e_1_3_2_3_11_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-09-2549"},{"key":"e_1_3_2_3_12_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.20.6789"},{"key":"e_1_3_2_3_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2012.03.004"},{"key":"e_1_3_2_3_14_1","doi-asserted-by":"publisher","DOI":"10.1186\/1479-5876-8-53"},{"key":"e_1_3_2_3_15_1","doi-asserted-by":"publisher","DOI":"10.1097\/PPO.0b013e31823261db"},{"key":"e_1_3_2_3_16_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1001294"},{"key":"e_1_3_2_4_2_1","unstructured":"Combination Immunotherapy With Herceptin and the HER2 Vaccine NeuVax. www.clinicaltrials.gov\/ct2\/show\/NCT01570036?term=NCT01570036&rank=1"},{"key":"e_1_3_2_4_3_1","unstructured":"Safety and Efficacy Study of HER2\/Neu (E75) Vaccine in Breast Cancer. www.clinicaltrials.gov\/ct2\/show\/NCT00854789?term=NCT00854789&rank=1"},{"key":"e_1_3_2_4_4_1","unstructured":"Pilot Study of a Breast Cancer Vaccine Plus Poly-ICLC for Breast Cancer (Breast 41). www.clinicaltrials.gov\/ct2\/show\/NCT01532960?term=NCT01532960&rank=1"},{"key":"e_1_3_2_4_5_1","unstructured":"Trial With Autologous Dendritic Cell Vaccination in Patients With Stage II-III HER2 Negative Breast Cancer. www.clinicaltrials.gov\/ct2\/show\/NCT01431196?term=NCT01431196&rank=1"},{"key":"e_1_3_2_4_6_1","unstructured":"Vaccine Therapy in Treating Patients With Previously Treated Stage II or Stage III Breast Cancer www.clinicaltrials.gov\/ct2\/show\/NCT00640861"}],"container-title":["Immunotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.2217\/imt.12.61","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T22:14:22Z","timestamp":1715984062000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.2217\/imt.12.61"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":21,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["10.2217\/imt.12.61"],"URL":"https:\/\/doi.org\/10.2217\/imt.12.61","relation":{},"ISSN":["1750-743X","1750-7448"],"issn-type":[{"value":"1750-743X","type":"print"},{"value":"1750-7448","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7]]}}}